MedTrace Logo

SPI-guided Analgesia During FESS for Intraoperative Blood Loss

NCT03417180 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2022-01-25

No results posted yet for this study

Summary

The aim of this randomized trial is to assess the utility of Surgical Pleth Index (SPI) for monitoring pain perception intraoperatively and its influence on intraoperative blood loss, quality of surgical field using Boezaart Bleeding Scale (BBS) in patients undergoing functional sinus surgery (FESS) under total intravenous anaesthesia using propofol or volatile anaesthesia using sevoflurane or desflurane

Conditions

  • Endoscopic Sinus Surgery

Interventions

DRUG

Remifentanil

a rate of infusion of reminfentanil will be increased by 50% every 5 minutes, until SPI value decreases back to baseline level

DEVICE

surgical pleth index

every time SPI value increases by 15 a rate of infusion of reminfentanil will be increased by 50% every 5 minutes

Sponsors & Collaborators

  • Medical University of Silesia

    lead OTHER

Principal Investigators

  • Przemysław O Jałowiecki, Ph. Dr · Medical University of Silesia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2023-07-15
Completion
2023-07-15

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03417180 on ClinicalTrials.gov